NORTH SHORE SURGERY — All Prescriptions & Medications — Page 13
Practice Code: P81681 | BLACKPOOL, FY2 0JG
Showing results 601-650 of 726
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| 18 | 2,340 | £783 | -34.1% ▼ | |
| Sucralfate | 17 | 6,200 | £7.3K | +102.4% ▲ |
| Testosterone esters | 17 | 57 | £133 | +15.3% ▲ |
| Denosumab | 17 | 17 | £3.1K | -37.5% ▼ |
| Pyridostigmine bromide | 17 | 3,400 | £268 | -0.7% vs avg |
| Betamethasone sodium phosphate | 17 | 170 | £38 | -34.4% ▼ |
| Apraclonidine | 17 | 1,428 | £6.5K | +35.0% ▲ |
| Heparinoid | 17 | 850 | £65 | +30.4% ▲ |
| Other individually formulated bought in preparations | 17 | 2,120 | £112 | -48.0% ▼ |
| 17 | 1,470 | £2.5K | -19.7% ▼ | |
| 17 | 129 | £223 | +3.0% ▲ | |
| 17 | 1,550 | £209 | -46.5% ▼ | |
| 17 | 1,400 | £287 | +132.7% ▲ | |
| 17 | 960 | £1.5K | +33.5% ▲ | |
| 17 | 810 | £1.1K | +94.0% ▲ | |
| Rabeprazole sodium | 16 | 840 | £86 | -69.0% ▼ |
| Hyoscine | 16 | 131 | £843 | +130.5% ▲ |
| Dapsone | 16 | 854 | £201 | +54.8% ▲ |
| 16 | 200 | £624 | -21.4% ▼ | |
| Clonidine hydrochloride | 15 | 888 | £69 | -17.9% ▼ |
| Valsartan with diuretic | 15 | 420 | £372 | +13.2% ▲ |
| Fluvoxamine maleate | 15 | 420 | £206 | +23.4% ▲ |
| Testosterone enantate | 15 | 15 | £484 | +110.0% ▲ |
| Ergocalciferol | 15 | 339 | £239 | -10.4% ▼ |
| Ready to serve 1.5 kcal/ml milkshake with fibre (0913021) | 15 | 168.0K | £4.4K | +8.6% ▲ |
| Powder amino acid formula (0913131) | 15 | 82.8K | £8.0K | +40.7% ▲ |
| Emulsifying wax | 15 | 7,500 | £47 | +23.1% ▲ |
| Other barrier preparations | 15 | 1,350 | £143 | +153.5% ▲ |
| 15 | 900 | £1.2K | +53.3% ▲ | |
| 15 | 2,430 | £3.9K | -18.5% ▼ | |
| 15 | 430 | £156 | -28.0% ▼ | |
| Dicycloverine hydrochloride | 14 | 1,176 | £1.5K | +18.3% ▲ |
| Buprenorphine hydrochloride | 14 | 784 | £162 | -97.8% ▼ |
| Oestrogens conjugated | 14 | 1,428 | £548 | -31.4% ▼ |
| Other health supplement preparations | 14 | 2,130 | £67 | -70.5% ▼ |
| Tablets/capsules micronutrient supplement (0913282) | 14 | 420 | £283 | +33.7% ▲ |
| 14 | 150 | £255 | +155.9% ▲ | |
| 14 | 153 | £122 | +41.2% ▲ | |
| 14 | 1,020 | £2.9K | +150.7% ▲ | |
| 14 | 400 | £1.9K | +68.6% ▲ | |
| 14 | 250 | £1.5K | +21.7% ▲ | |
| Telmisartan with diuretic | 13 | 364 | £100 | +15.0% ▲ |
| Cilostazol | 13 | 728 | £410 | -6.3% ▼ |
| Omega-3-acid ethyl esters | 13 | 1,456 | £704 | -38.5% ▼ |
| Gemfibrozil | 13 | 364 | £221 | +28.7% ▲ |
| Indacaterol/glycopyrronium | 13 | 390 | £402 | -71.2% ▼ |
| Flupentixol hydrochloride | 13 | 1,092 | £146 | -40.7% ▼ |
| Flupentixol decanoate | 13 | 26 | £64 | -18.6% ▼ |
| Trimipramine maleate | 13 | 364 | £1.4K | -18.4% ▼ |
| Meptazinol hydrochloride | 13 | 728 | £138 | -60.7% ▼ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.